How shorted is Intellia Therapeutics, Inc. right now?

31.41% of Intellia Therapeutics, Inc.'s (NTLA) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.

What does this number include?

FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.

Why does it only update twice a month?

US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.

Which funds are short?

US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.

How shorted is Intellia Therapeutics, Inc.?

More shorted than 99% of the 2,877 ranked US companies

31.41%

of shares outstanding reported short · settlement date 31 Jul 2026

vs previous report: −1.35
5 reports (~10 weeks): −5.70

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

<iframe src="https://howshorted.com/embed/us/ntla/" width="100%" height="430" style="border:0" loading="lazy" title="Intellia Therapeutics, Inc. short interest chart"></iframe>
<p>Source: FINRA data compiled by <a href="https://howshorted.com/us/company/ntla/">howshorted.com</a></p>

Cite this page

Short position data for Intellia Therapeutics, Inc.: FINRA, compiled by howshorted.com, settlement date 31 Jul 2026. https://howshorted.com/us/company/ntla/

History

Settlement date	Short %	Change
31 Jul 2026	31.41%	−1.35
15 Jul 2026	32.76%	−2.47
30 Jun 2026	35.23%	−0.78
15 Jun 2026	36.01%	+1.29
29 May 2026	34.72%	−2.39
15 May 2026	37.11%	+5.95
30 Apr 2026	31.16%	−1.69
15 Apr 2026	32.85%	−0.12
31 Mar 2026	32.97%	−0.42
13 Mar 2026	33.39%	−4.12
27 Feb 2026	37.51%	−0.80
13 Feb 2026	38.31%	−0.82
30 Jan 2026	39.13%	+2.39
15 Jan 2026	36.74%	+0.86
31 Dec 2025	35.88%	+0.85
15 Dec 2025	35.03%	−3.45
28 Nov 2025	38.48%	+3.74
14 Nov 2025	34.74%	+1.00
31 Oct 2025	33.74%	+4.95
15 Oct 2025	28.79%	+1.09
30 Sep 2025	27.70%	−4.10
15 Sep 2025	31.80%	+5.96
29 Aug 2025	25.84%	+0.01
15 Aug 2025	25.83%	−1.85
31 Jul 2025	27.68%	–

Frequently asked questions

How shorted is Intellia Therapeutics, Inc. right now?: 31.41% of Intellia Therapeutics, Inc.'s (NTLA) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?: FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?: US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?: US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.